Zensar’s acquisition of BridgeView Life Sciences enhances our ability to support product launches and commercialization for pharma and medtech companies. This strategic move expands our offerings for existing clients while enabling us to serve innovative and emerging players. BridgeView’s expertise as a Veeva “Preferred Services Partner,” with specialization in Veeva Vault Clinical, Quality, and RIM, strengthens our position as a trusted technology partner. Combined with Zensar’s global capabilities across SaaS (SFDC, ERP), experience, analytics and Gen AI, cloud, infrastructure, and agency services, we deliver scalable digital solutions that transform engagement and improve patient outcomes.
What sets us apart
